肝性脊髓病1例分析(4)
[16] Panicker J，Sinha S，Taly AB，et al.Hepatic myelopathy：A rare complication following extrahepatic portal vein occlusionand 1ienorena1 shunt[J].Neuro1 India，2006，54(3)：298-300.
[17] Nardone R，buratti T，Oliviero A，et al.Corticospina1 involvement in patients with a portosystemic shunt due to liver cirrhosis：A MEP study[J].J Neurol，2006，253(1)：81-85.
[18] Wang MQ，Dake MD，Cui ZP，et al.Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation：Report of four cases[J]. J Vasc Interv Radio1，12(7)：879-881.
[19] Campellone JV，Lacomis D，Guliani MJ，et al.Hepatic myelopathy.case report with review of the literature[J].Clin Neurosurg，1996，98(3)：242-246.
[20] Weissenborn K，Tietge UJ，Bokemeyer M，et al.Liver transplantation improves hepatic myelopathy：evidence by three cases[J].J Gastroentero1ogy，2003，124(2)：346-351.
[21] Troisi R，Debruyne J，de Hemptinne B.Improvement of hepatic myelopathy after liver transp1antation[J].N Engl J Med，1999，340(2)：151.
[22] Caldwell C，Werdiger N，Jakab S，et al.Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature[J].Liver Transpl，2010，16(7)：818-826.
[23] Baccarani U，Zola E，Adani GL，et al.Reversal of hepatic myelopathy after liver transplantation：fifteen plus one[J].Liver Transpl，2010，16(11)：1336-1337.
(收稿日期：2012-07-03), 百拇医药(王仁忠?梁红丽?贾雪莉)
[17] Nardone R，buratti T，Oliviero A，et al.Corticospina1 involvement in patients with a portosystemic shunt due to liver cirrhosis：A MEP study[J].J Neurol，2006，253(1)：81-85.
[18] Wang MQ，Dake MD，Cui ZP，et al.Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation：Report of four cases[J]. J Vasc Interv Radio1，12(7)：879-881.
[19] Campellone JV，Lacomis D，Guliani MJ，et al.Hepatic myelopathy.case report with review of the literature[J].Clin Neurosurg，1996，98(3)：242-246.
[20] Weissenborn K，Tietge UJ，Bokemeyer M，et al.Liver transplantation improves hepatic myelopathy：evidence by three cases[J].J Gastroentero1ogy，2003，124(2)：346-351.
[21] Troisi R，Debruyne J，de Hemptinne B.Improvement of hepatic myelopathy after liver transp1antation[J].N Engl J Med，1999，340(2)：151.
[22] Caldwell C，Werdiger N，Jakab S，et al.Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature[J].Liver Transpl，2010，16(7)：818-826.
[23] Baccarani U，Zola E，Adani GL，et al.Reversal of hepatic myelopathy after liver transplantation：fifteen plus one[J].Liver Transpl，2010，16(11)：1336-1337.
(收稿日期：2012-07-03), 百拇医药(王仁忠?梁红丽?贾雪莉)